70 Indian entrepreneurs set to benefit from Mitap agricultural grants
Malaysian Indian Transformation Unit (Mitra) special task force committee chairman P. Prabakaran (pic) said the programme, organised by Mitra in collaboration with Mardi Corporation Sdn Bhd, focuses on developing the capacity of Indian entrepreneurs in the modern agriculture and food processing sectors.
"Mitra received more than 250 applications for Mitap, and a total of 104 participants attended the Business Model Canvas (BMC) Seminar on Wednesday (July 30), which is a basic module in forming a sustainable business.
"Through the BMC, we will assess each individual based on their proposal paper and the potential of the project to be developed," he told reporters after officiating the seminar at the MardiCorp Academy here on Wednesday.
The two-day seminar aims to help participants enhance their competitiveness, strengthen entrepreneurial skills, and expand their business networks.
Prabakaran said Mitra and Mardi Corp would continue to strengthen the government's commitment to empowering the Indian community by providing a comprehensive agricultural ecosystem, including up-to-date technical training.
"Mitap is not only a symbol of support for the Indian community, but also a reflection of the government's determination to ensure the community is not left behind in the development of the modern agricultural sector," he said.
Meanwhile, Mardi Governing Board chairman Dr Azman Ismail said he was optimistic that the strategic partnership between Mitra and Mardi Corp would lead to the emergence of more successful Indian entrepreneurs.
"Mardi has a long history of working with many successful entrepreneurs, including Ramly Burger and Adabi.
"I am confident that several more entrepreneurs will emerge from here (Mitap). This batch seems more promising because the programme is now better organised and more systematic. In the past, participants had to figure things out on their own with little guidance," he said.- Bernama
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
an hour ago
- The Star
Oil prices fall on Opec+ output hikes
Brent crude futures settled US$1.12, or 1.63%, lower to US$67.64 a barrel, while US West Texas Intermediate crude slipped US$1.13, or 1.7%, to US$65.16. NEW YORK: Oil prices slipped on Tuesday as rising Opec+ supply and worries of weaker global demand countered concern about US President Donald Trump's threats to India over its Russian oil purchases. Brent crude futures settled US$1.12, or 1.63%, lower to US$67.64 a barrel, while US West Texas Intermediate crude slipped US$1.13, or 1.7%, to US$65.16. Both benchmarks settled to their lowest in five weeks. The Organization of the Petroleum Exporting Countries and its allies, together known as Opec+, agreed on Sunday to raise oil production by 547,000 barrels per day for September, a move that will end its most recent output cut earlier than planned. "The significant increase in Opec supplies is weighing on the market," said Andrew Lipow, president of Lipow Oil Associates. Also weighing on prices, US services sector activity unexpectedly flatlined in July with little change in orders and a further weakening in employment even as input costs climbed by the most in nearly three years, underscoring the ongoing drag of uncertainty over the Trump administration's tariff policy on businesses. "The market now is going to see if India and China agree to substantially reduce the purchases of Russian crude oil, thereby looking for alternative supplies elsewhere," Lipow said. Trump on Tuesday again threatened higher tariffs on Indian goods over the country's Russian oil purchases over the next 24 hours. Trump also said declining energy prices could pressure Russian President Vladimir Putin to halt the war in Ukraine. New Delhi called Trump's threat "unjustified" and vowed to protect its economic interests, deepening a trade rift between the two countries. Oil's move since Trump's threat indicates that traders are sceptical of a supply disruption happening, John Evans of oil broker PVM said in a report. He questioned whether Trump would risk higher oil prices. "I'd call it a stable market for oil," said Giovanni Staunovo, an analyst at UBS. "Assume this likely continues until we figure out what the US president announces in respect to Russia later this week and how those buyers would react." India is the biggest buyer of seaborne crude from Russia, importing about 1.75 million bpd from January to June this year, up 1% from a year ago, according to data provided to Reuters by trade sources. US crude inventories fell by 4.2 million barrels last week, sources citing American Petroleum Institute figures said on Tuesday. The US Energy Information Administration is due to release weekly U.S. inventory data on Wednesday, respectively. — Reuters
New Straits Times
2 hours ago
- New Straits Times
Trump says pharma, chips tariffs incoming as trade war widens
WASHINGTON: US President Donald Trump signalled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled within the coming week, as a cascade of incoming duties promises to reshape global trading ties. Governments around the world are bracing as new waves of US tariffs are due to take effect this week, first on many Brazilian products Wednesday and then on dozens of other economies – including the European Union and Taiwan – beginning Thursday. Trump's sweeping plans have sparked a flurry of activity as leaders seek to avert the worst of his threats, with Swiss officials heading to Washington on Tuesday in a last-minute push to avoid punitive duties. But the US president appears set to widen his trade wars. Trump told CNBC on Tuesday that upcoming tariffs on imported pharmaceuticals could reach 250 per cent, while adding that he plans for new duties on foreign semiconductors soon. "We'll be putting (an) initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150 per cent," Trump said. "And then it's going to go to 250 per cent because we want pharmaceuticals made in our country." Trump also said that Washington will be announcing tariffs "within the next week or so." He added: "We're going to be announcing on semiconductors and chips." Trump has set out varying tariff rates for dozens of economies after imposing a 10 per cent levy on almost all trading partners in April. But these broad duties taking effect Thursday exclude products like pharmaceuticals, steel, aluminium and lumber, which are being separately targeted by sector. This means that although the 39 per cent tariff Swiss leaders seek to avoid come Thursday excludes pharmaceuticals, Trump's plans for a steep levy on such imports will likely remain a point of contention in any talks. Pharmaceuticals represented 60 per cent of Swiss goods exports to the United States last year. Outside of Switzerland, most products from the European Union face a 15 per cent tariff starting Thursday, after Washington and Brussels struck a deal to avoid higher levies. But Trump warned Tuesday that the EU could see its tariff level surge again if it did not fulfil obligations under their recent pact. Some imports from Canada are also targeted by tariffs, although Prime Minister Mark Carney stressed Tuesday that more than 85 per cent of trade between the North American neighbours remains tariff-free under existing exemptions. Besides probing pharmaceuticals and chips imports, Trump has already imposed steep duties of 50 per cent on steel and aluminium, alongside lower levies on autos and parts. In the same CNBC interview Tuesday, Trump said he expects to raise the US tariff on Indian imports "very substantially over the next 24 hours" due to the country's purchases of Russian oil. This is a key revenue source for Moscow's military offensive on Ukraine. His pressure on India comes after signalling fresh sanctions on Moscow if it did not make progress by Friday towards a peace deal with Kyiv, more than three years since Russia's invasion. Moscow is anticipating talks this week with the US leader's special envoy Steve Witkoff, and the Kremlin has criticised Trump's threat of raising tariffs on Indian goods. Weak employment data last week pointed to challenges for the US economy as companies take a cautious approach in hiring and investment while grappling with Trump's radical – and rapidly changing – trade policy. The tariffs are a demonstration of raw economic power that Trump sees as putting US exporters in a stronger position while encouraging domestic manufacturing by keeping out foreign imports. But the approach has raised fears of inflation and other economic fallout in the world's biggest economy.
The Sun
9 hours ago
- The Sun
Trump proposes 250% tariff on imported pharmaceuticals
WASHINGTON: US President Donald Trump revealed plans to impose tariffs on imported pharmaceuticals that could escalate to 250%, alongside new duties on foreign semiconductors. The move aims to push for domestic manufacturing of critical goods. 'We'll be putting (an) initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150 percent,' Trump said in an interview on CNBC. 'And then it's going to go to 250 percent because we want pharmaceuticals made in our country.' The announcement follows earlier tariffs on steel, aluminum, and auto parts, part of Trump's broader trade strategy targeting imports deemed a national security concern. The administration has conducted investigations into pharmaceuticals and semiconductors, signaling upcoming policy shifts. Trump also indicated an imminent increase in tariffs on Indian imports, citing the country's purchases of Russian oil. 'I expect to raise the US tariff on Indian imports very substantially over the next 24 hours,' he said. The proposed pharmaceutical tariffs mark a significant escalation in trade measures, potentially disrupting global supply chains. Industry analysts warn of higher drug prices, while supporters argue it will strengthen US self-sufficiency. - AFPpix
